Dear Mr. Reichenbach,
It’ is more than urgent to cover economic deficiencies of EOPYY. The present situation in the whole health sector consists a real sanitary crisis in Greece. The health system collapses. It is crucial to finance EOPYY with € 1,5 bio to cover its financial commitments regarding medicines within community pharmacies and hospitals and also regarding the providers of the whole supply chain. Patients cannot afford to pay for their own medicines and at the same time hospital departments of crucial importance are closing down, due to lack of supplies.
To this unbearable situation is added the ever increasing number of shortages of medicines.
According to law 4038/2012 the State should have already financed EOPYY with the
amount of € 1.5 bio; this however never happened. This legislative provision concerning the fiscal support of EOPYY was agreed with the European auditors and the EU Task Force for Greece. Thus, it is extremely urgent either to transfer the above amount from the Ministry of Finance, which given the
circumstances cannot be effected, or to ask the European Commission in excess of
the financing already agreed upon, to cover this deficiency.
We address a plea because the life of patients is at stake.
We would kindly like to ask you to arrange a meeting at your earliest convenience to
discuss in detail this crucial matter.
Sincerely,
Konstantinos M. Frouzis Dimitrios Demos
President, SFEE (Hellenic Association President, PEF (Panhellenic Union
of Pharmaceutical Companies) of Pharmaceutical Industry)
Theodoros Ampatzoglou Manolis Katsaris
President, Panhellenic President, Panhellenic
Pharmaceutical Association Association of Pharmaceutical
Wholesalers (P.A.P.W.)
Andreas Galanopoulos
President, Federation of
Cooperative Pharmacists of
Greece
It’ is more than urgent to cover economic deficiencies of EOPYY. The present situation in the whole health sector consists a real sanitary crisis in Greece. The health system collapses. It is crucial to finance EOPYY with € 1,5 bio to cover its financial commitments regarding medicines within community pharmacies and hospitals and also regarding the providers of the whole supply chain. Patients cannot afford to pay for their own medicines and at the same time hospital departments of crucial importance are closing down, due to lack of supplies.
To this unbearable situation is added the ever increasing number of shortages of medicines.
According to law 4038/2012 the State should have already financed EOPYY with the
amount of € 1.5 bio; this however never happened. This legislative provision concerning the fiscal support of EOPYY was agreed with the European auditors and the EU Task Force for Greece. Thus, it is extremely urgent either to transfer the above amount from the Ministry of Finance, which given the
circumstances cannot be effected, or to ask the European Commission in excess of
the financing already agreed upon, to cover this deficiency.
We address a plea because the life of patients is at stake.
We would kindly like to ask you to arrange a meeting at your earliest convenience to
discuss in detail this crucial matter.
Sincerely,
Konstantinos M. Frouzis Dimitrios Demos
President, SFEE (Hellenic Association President, PEF (Panhellenic Union
of Pharmaceutical Companies) of Pharmaceutical Industry)
Theodoros Ampatzoglou Manolis Katsaris
President, Panhellenic President, Panhellenic
Pharmaceutical Association Association of Pharmaceutical
Wholesalers (P.A.P.W.)
Andreas Galanopoulos
President, Federation of
Cooperative Pharmacists of
Greece